153 related articles for article (PubMed ID: 8820676)
1. [An experimental study of the immunogenic and protective properties of Coxiella burnetii strain M-44 and a live enteral vaccine against Q fever].
Mikhaĭlov VV; Vorob'ev AA; Makhlaĭ AA; Khaltaeva GG; Suvorova TA; Krasnianskiĭ VP; Iakovlev EA; Pashanin IuG; Dykanov GA; Podkuĭko VN; Lebedinskaia EV
Zh Mikrobiol Epidemiol Immunobiol; 1996; (1):38-42. PubMed ID: 8820676
[TBL] [Abstract][Full Text] [Related]
2. The Feasibility of Using
Kumaresan V; Alam S; Zhang Y; Zhang G
Front Immunol; 2021; 12():754690. PubMed ID: 34795669
[TBL] [Abstract][Full Text] [Related]
3. Balb/c mouse model and real-time quantitative polymerase chain reaction for evaluation of the immunoprotectivity against Q fever.
Zhang J; Wen B; Chen M; Zhang J; Niu D
Ann N Y Acad Sci; 2005 Dec; 1063():171-5. PubMed ID: 16481510
[TBL] [Abstract][Full Text] [Related]
4. Coxiella burnetii Intratracheal Aerosol Infection Model in Mice, Guinea Pigs, and Nonhuman Primates.
Gregory AE; van Schaik EJ; Russell-Lodrigue KE; Fratzke AP; Samuel JE
Infect Immun; 2019 Dec; 87(12):. PubMed ID: 31501249
[No Abstract] [Full Text] [Related]
5. Promiscuous
Scholzen A; Richard G; Moise L; Baeten LA; Reeves PM; Martin WD; Brauns TA; Boyle CM; Raju Paul S; Bucala R; Bowen RA; Garritsen A; De Groot AS; Sluder AE; Poznansky MC
Front Immunol; 2019; 10():207. PubMed ID: 30828331
[No Abstract] [Full Text] [Related]
6. Soluble antigens derived from
Gregory AE; van Schaik EJ; Fratzke AP; Russell-Lodrigue KE; Farris CM; Samuel JE
Cell Rep Med; 2021 Dec; 2(12):100461. PubMed ID: 35028605
[TBL] [Abstract][Full Text] [Related]
7. Subunit Vaccines Using TLR Triagonist Combination Adjuvants Provide Protection Against
Fratzke AP; Jan S; Felgner J; Liang L; Nakajima R; Jasinskas A; Manna S; Nihesh FN; Maiti S; Albin TJ; Esser-Kahn AP; Davies DH; Samuel JE; Felgner PL; Gregory AE
Front Immunol; 2021; 12():653092. PubMed ID: 33815413
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of cynomolgus (Macaca fascicularis) and rhesus (Macaca mulatta) monkeys as experimental models of acute Q fever after aerosol exposure to phase-I Coxiella burnetii.
Waag DM; Byrne WR; Estep J; Gibbs P; Pitt ML; Banfield CM
Lab Anim Sci; 1999 Dec; 49(6):634-8. PubMed ID: 10638499
[TBL] [Abstract][Full Text] [Related]
9. Vaccines against coxiellosis and Q fever. Development of a chloroform:methanol residue subunit of phase I Coxiella burnetti for the immunization of animals.
Williams JC; Peacock MG; Waag DM; Kent G; England MJ; Nelson G; Stephenson EH
Ann N Y Acad Sci; 1992 Jun; 653():88-111. PubMed ID: 1626897
[TBL] [Abstract][Full Text] [Related]
10. [A comparative study of Coxiella burnetii strains differing in virulence in the intratracheal infection of guinea pigs].
Suvorova TA; Pshenichnov VA; Grabarev PA
Zh Mikrobiol Epidemiol Immunobiol; 1997; (2):14-7. PubMed ID: 9245132
[TBL] [Abstract][Full Text] [Related]
11. Coxiella burnetii persistence in three generations of mice after application of live attenuated human M-44 vaccine against Q fever.
Freylikhman O; Tokarevich N; Suvorov A; Vorobiova E; Totolian A
Ann N Y Acad Sci; 2003 Jun; 990():496-9. PubMed ID: 12860680
[No Abstract] [Full Text] [Related]
12. Protective immunity induced by 67 K outer membrane protein of phase I Coxiella burnetii in mice and guinea pigs.
Zhang YX; Zhi N; Yu SR; Li QJ; Yu GQ; Zhang X
Acta Virol; 1994 Dec; 38(6):327-32. PubMed ID: 7793356
[TBL] [Abstract][Full Text] [Related]
13. Coxiella burnetii: host and bacterial responses to infection.
Waag DM
Vaccine; 2007 Oct; 25(42):7288-95. PubMed ID: 17825460
[TBL] [Abstract][Full Text] [Related]
14. Comparative efficacy of a Coxiella burnetii chloroform:methanol residue (CMR) vaccine and a licensed cellular vaccine (Q-Vax) in rodents challenged by aerosol.
Waag DM; England MJ; Pitt ML
Vaccine; 1997 Nov; 15(16):1779-83. PubMed ID: 9364683
[TBL] [Abstract][Full Text] [Related]
15. Comparative efficacy and immunogenicity of Q fever chloroform:methanol residue (CMR) and phase I cellular (Q-Vax) vaccines in cynomolgus monkeys challenged by aerosol.
Waag DM; England MJ; Tammariello RF; Byrne WR; Gibbs P; Banfield CM; Pitt ML
Vaccine; 2002 Jun; 20(19-20):2623-34. PubMed ID: 12057622
[TBL] [Abstract][Full Text] [Related]
16. Components of protective immunity.
Zhang G; Zhang Y; Samuel JE
Adv Exp Med Biol; 2012; 984():91-104. PubMed ID: 22711628
[TBL] [Abstract][Full Text] [Related]
17. Development of a lipopolysaccharide-targeted peptide mimic vaccine against Q fever.
Peng Y; Zhang Y; Mitchell WJ; Zhang G
J Immunol; 2012 Nov; 189(10):4909-20. PubMed ID: 23053512
[TBL] [Abstract][Full Text] [Related]
18. Enhanced protection against Q fever in BALB/c mice elicited by immunization of chloroform-methanol residue of Coxiella burnetii via intratracheal inoculation.
Feng J; Hu X; Fu M; Dai L; Yu Y; Luo W; Zhao Z; Lu Z; Du Z; Zhou D; Wen B; Jiao J; Xiong X
Vaccine; 2019 Sep; 37(41):6076-6084. PubMed ID: 31477436
[TBL] [Abstract][Full Text] [Related]
19. Identification of Coxiella burnetii CD8+ T-Cell Epitopes and Delivery by Attenuated Listeria monocytogenes as a Vaccine Vector in a C57BL/6 Mouse Model.
Xiong X; Jiao J; Gregory AE; Wang P; Bi Y; Wang X; Jiang Y; Wen B; Portnoy DA; Samuel JE; Chen C
J Infect Dis; 2017 May; 215(10):1580-1589. PubMed ID: 27703037
[TBL] [Abstract][Full Text] [Related]
20. Protective immunity against Q fever induced with a recombinant P1 antigen fused with HspB of Coxiella burnetii.
Li Q; Niu D; Wen B; Chen M; Qiu L; Zhang J
Ann N Y Acad Sci; 2005 Dec; 1063():130-42. PubMed ID: 16481504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
